Le Lézard
Classified in: Business

Middlefield Group Opens the Market


TORONTO, Dec. 9, 2019 /CNW/ - Dean Orrico, President and Chief Investment Officer, Middlefield Capital Corporation, joined Graham MacKenzie, Head, ETFs and Structured Products, Toronto Stock Exchange, to open the market to celebrate the launch of Middlefield Global Real Asset Fund (RA.UN). Formed in 1979, Middlefield creates and manages specialized investment products for individual and institutional investors and holds approximately $4 billion in assets under management. Investment products include exchange-traded funds, mutual funds, closed-end funds, private and public resource funds, hedge funds, real estate funds and a venture capital fund. RA.UN commenced trading on Toronto Stock Exchange on November 26, 2019.

SOURCE TMX Group Limited


These press releases may also interest you

at 08:03
The American Red Cross celebrates The Church of Jesus Christ of Latter-day Saints, headquartered in Salt Lake City, for its substantial donation of $7.35 million. The gift will help purchase blood equipment and biomedical emergency vehicles and will...

at 08:00
Bidpath Inc., a leading provider of global online auction software, proudly announces the launch of AuctionPay, a cutting-edge payments platform designed to revolutionize auction payments. With a focus on efficiency, security, and user-centric...

at 08:00
SC Ventures, Standard Chartered's innovation, fintech investment and ventures arm, is leading a ?12 million (USD $13 million) Series A round for distributed cloud provider Hive, to increase access to sustainable, high-powered computing resources for...

at 08:00
Callon Petroleum Company ("Callon" or the "Company") today announced the expiration and final tender results of its previously announced cash tender offers (the "Offers") for any and all of its 8.000% Senior Notes due 2028 (the "2028 Notes") and any...

at 08:00
The parties in Severa, et al. v. Solvay Specialty Polymers USA, LLC, et al., announce that Judge Noel Hillman of the United States District Court for the District of New Jersey has preliminarily approved a class action settlement. The hearing on...

at 08:00
PassPort Technologies, Inc. (PPTI), based in San Diego, a clinical-stage drug and medical device development company, today announced positive interim results from the Phase 1 (Part A) clinical trial of Zolmitriptan PassPort® utilizing its...



News published on and distributed by: